Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

miR-375 activates p21 and suppresses telomerase activity by coordinately regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3ζ.

Jung HM, Phillips BL, Chan EK.

Mol Cancer. 2014 Apr 8;13:80. doi: 10.1186/1476-4598-13-80.

2.

Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.

Honegger A, Schilling D, Bastian S, Sponagel J, Kuryshev V, Sültmann H, Scheffner M, Hoppe-Seyler K, Hoppe-Seyler F.

PLoS Pathog. 2015 Mar 11;11(3):e1004712. doi: 10.1371/journal.ppat.1004712. eCollection 2015 Mar.

5.

A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.

Yew CW, Lee P, Chan WK, Lim VK, Tay SK, Tan TM, Deng LW.

Cancer Res. 2011 Nov 1;71(21):6696-707. doi: 10.1158/0008-5472.CAN-11-1271. Epub 2011 Sep 9.

6.
7.

Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.

Moon MS, Lee CJ, Um SJ, Park JS, Yang JM, Hwang ES.

Gynecol Oncol. 2001 Feb;80(2):168-75.

PMID:
11161855
8.

Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein.

Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY, Lu WG, Xie X.

Eur J Cancer. 2011 Sep;47(14):2166-74. doi: 10.1016/j.ejca.2011.04.037. Epub 2011 Jun 1.

PMID:
21636267
9.

E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.

Wu L, Goodwin EC, Naeger LK, Vigo E, Galaktionov K, Helin K, DiMaio D.

Mol Cell Biol. 2000 Oct;20(19):7059-67.

10.

Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.

Zhang H, Jin Y, Chen X, Jin C, Law S, Tsao SW, Kwong YL.

Cancer Lett. 2007 Jan 8;245(1-2):184-94. Epub 2006 Feb 20.

PMID:
16488074
12.

Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.

Rampias T, Boutati E, Pectasides E, Sasaki C, Kountourakis P, Weinberger P, Psyrri A.

Mol Cancer Res. 2010 Mar;8(3):433-43. doi: 10.1158/1541-7786.MCR-09-0345. Epub 2010 Mar 9.

13.

NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.

Katzenellenbogen RA, Egelkrout EM, Vliet-Gregg P, Gewin LC, Gafken PR, Galloway DA.

J Virol. 2007 Apr;81(8):3786-96. Epub 2007 Jan 31.

14.

Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6.

Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, Meyers C, Chow LT, Zheng ZM.

RNA. 2009 Apr;15(4):637-47. doi: 10.1261/rna.1442309. Epub 2009 Mar 3.

15.

Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function.

Cherry JJ, Rietz A, Malinkevich A, Liu Y, Xie M, Bartolowits M, Davisson VJ, Baleja JD, Androphy EJ.

PLoS One. 2013 Dec 23;8(12):e84506. doi: 10.1371/journal.pone.0084506. eCollection 2013.

16.

The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.

Liu X, Yuan H, Fu B, Disbrow GL, Apolinario T, Tomaic V, Kelley ML, Baker CC, Huibregtse J, Schlegel R.

J Biol Chem. 2005 Mar 18;280(11):10807-16. Epub 2005 Jan 17.

17.

Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.

Matsumoto Y, Nakagawa S, Yano T, Takizawa S, Nagasaka K, Nakagawa K, Minaguchi T, Wada O, Ooishi H, Matsumoto K, Yasugi T, Kanda T, Huibregtse JM, Taketani Y.

J Med Virol. 2006 Apr;78(4):501-7.

PMID:
16482544
18.

RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.

Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D.

Apoptosis. 2008 Feb;13(2):273-81.

PMID:
18060502
19.

Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells.

Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC.

Mol Cancer. 2011 Apr 15;10:39. doi: 10.1186/1476-4598-10-39.

Items per page

Supplemental Content

Write to the Help Desk